Mingfeng Xia

4.0k total citations · 1 hit paper
98 papers, 2.7k citations indexed

About

Mingfeng Xia is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Mingfeng Xia has authored 98 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Epidemiology, 40 papers in Endocrinology, Diabetes and Metabolism and 29 papers in Physiology. Recurrent topics in Mingfeng Xia's work include Liver Disease Diagnosis and Treatment (58 papers), Diet, Metabolism, and Disease (29 papers) and Diet and metabolism studies (15 papers). Mingfeng Xia is often cited by papers focused on Liver Disease Diagnosis and Treatment (58 papers), Diet, Metabolism, and Disease (29 papers) and Diet and metabolism studies (15 papers). Mingfeng Xia collaborates with scholars based in China, United States and Finland. Mingfeng Xia's co-authors include Xin Gao, Hua Bian, Hongmei Yan, Xinxia Chang, Huandong Lin, Hui Ma, Xiuzhong Yao, Xiaopeng Zhu, Wanyuan He and Qiqige Aleteng and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Mingfeng Xia

96 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER

2024 46 citations Mingfeng Xia et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingfeng Xia China	27	1.5k	913	747	532	341	98	2.7k
Hua Bian China	26	1.2k 0.8×	583 0.6×	665 0.9×	292 0.5×	230 0.7×	77	2.0k
Esther Titos Spain	37	1.7k 1.2×	520 0.6×	1.1k 1.4×	871 1.6×	333 1.0×	67	4.1k
Liang Xu China	25	990 0.7×	645 0.7×	676 0.9×	474 0.9×	102 0.3×	69	2.2k
Federico Salomone Italy	23	1.2k 0.8×	661 0.7×	343 0.5×	377 0.7×	211 0.6×	34	1.8k
Cristina López‐Vicario Spain	28	1.2k 0.8×	315 0.3×	755 1.0×	568 1.1×	106 0.3×	44	2.6k
Ana González‐Périz Spain	20	1.1k 0.7×	376 0.4×	717 1.0×	602 1.1×	152 0.4×	24	2.4k
Marenao Tanaka Japan	27	943 0.6×	550 0.6×	857 1.1×	401 0.8×	191 0.6×	91	2.4k
Lance Yi Xu New Zealand	11	2.2k 1.5×	585 0.6×	701 0.9×	920 1.7×	100 0.3×	12	2.8k
Francesco Baratta Italy	28	1.5k 1.0×	806 0.9×	462 0.6×	602 1.1×	51 0.1×	81	2.4k
Renata Belfort United States	14	1.8k 1.2×	1.3k 1.5×	1.0k 1.4×	1.0k 1.9×	95 0.3×	16	3.1k

Countries citing papers authored by Mingfeng Xia

Since Specialization

Citations

This map shows the geographic impact of Mingfeng Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingfeng Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingfeng Xia more than expected).

Fields of papers citing papers by Mingfeng Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingfeng Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingfeng Xia. The network helps show where Mingfeng Xia may publish in the future.

Co-authorship network of co-authors of Mingfeng Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Mingfeng Xia. A scholar is included among the top collaborators of Mingfeng Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingfeng Xia. Mingfeng Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xia, Mingfeng, Yuxiang Dai, Qingxia Huang, et al.. (2025). Cross-ancestry analyses of Chinese and European populations reveal insights into the genetic architecture and disease implication of metabolites. Cell Genomics. 5(4). 100810–100810. 2 indexed citations

Liao, Kaili, Beining Zhang, Xue Zhang, et al.. (2025). The role of intratumoral microbiome in the occurrence, proliferation, metastasis of colorectal cancer and its underlying therapeutic strategies. Ageing Research Reviews. 111. 102820–102820. 2 indexed citations

Zhu, Xiaopeng, Qingxia Huang, Hongmei Yan, et al.. (2024). Increased serum β-hydroxybutyrate/acetoacetate ratio and aggravated histological liver inflammation in females with metabolic dysfunction-associated steatotic liver disease and polycystic ovary syndrome. Journal of Molecular Cell Biology. 16(11). 2 indexed citations

Zhai, Tianyu, Liang Cai, Mingfeng Xia, et al.. (2024). IGFBP2 functions as an endogenous protector against hepatic steatosis via suppression of the EGFR-STAT3 pathway. Molecular Metabolism. 89. 102026–102026. 2 indexed citations

Huang, Qingxia, S. U. Qadri, Hua Bian, et al.. (2024). A metabolome-derived score predicts metabolic dysfunction-associated steatohepatitis and mortality from liver disease. Journal of Hepatology. 82(5). 781–793. 7 indexed citations

Zhang, Yuying, Haifu Wu, Hongmei Yan, et al.. (2024). Characteristics of changes in plasma proteome profiling after sleeve gastrectomy. Frontiers in Endocrinology. 15. 1330139–1330139. 1 indexed citations

Dān, Wèi, Xinmei Wang, Jiaqi Wu, et al.. (2023). The early effects of sleeve gastrectomy on postprandial chylomicron triglycerides during the progression of type 2 diabetes. Clinica Chimica Acta. 549. 117558–117558. 1 indexed citations

Wu, Qi, Mingfeng Xia, & Xīn Gào. (2022). Metabolically healthy obesity: Is it really healthy for type 2 diabetes mellitus?. World Journal of Diabetes. 13(2). 70–84. 8 indexed citations

Li, Xiaoming, Mingfeng Xia, Hui Ma, et al.. (2021). Liver fat content is independently associated with microalbuminuria in a normotensive, euglycaemic Chinese population: a community-based, cross-sectional study. BMJ Open. 11(6). e044237–e044237. 1 indexed citations

10.

Li, Yufeng, Jun‐Yu Xu, Yuting Lu, et al.. (2021). DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing. Cell Metabolism. 33(10). 2004–2020.e9. 60 indexed citations

11.

Yang, Xinyu, et al.. (2021). Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids in Health and Disease. 20(1). 126–126. 16 indexed citations

12.

Chen, Lingyan, Mingfeng Xia, Li Wu, et al.. (2021). Skeletal muscle loss is associated with diabetes in middle-aged and older Chinese men without non-alcoholic fatty liver disease. World Journal of Diabetes. 12(12). 2119–2129. 9 indexed citations

13.

Yan, Hongmei, Weiyun Wu, Xinxia Chang, et al.. (2021). Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism. Biology of Sex Differences. 12(1). 1–1. 25 indexed citations

14.

Xia, Mingfeng, et al.. (2017). Hypokalemia, hypomagnesemia, hypocalciuria, and recurrent tetany: Gitelman syndrome in a Chinese pedigree and literature review. Clinical Case Reports. 5(5). 578–586. 8 indexed citations

15.

Xia, Mingfeng, Hua Bian, Xiaopeng Zhu, et al.. (2017). Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults. Clinical Nutrition. 37(5). 1752–1758. 37 indexed citations

16.

Xia, Mingfeng, Ying Chen, Huandong Lin, et al.. (2016). A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Scientific Reports. 6(1). 38214–38214. 164 indexed citations

17.

Yan, Hongmei, Mingfeng Xia, Xinxia Chang, et al.. (2015). Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease. PLoS ONE. 10(8). e0134172–e0134172. 180 indexed citations

18.

Lin, Huandong, Qian Li, Xiaojing Liu, et al.. (2015). Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study. PLoS ONE. 10(10). e0140379–e0140379. 9 indexed citations

19.

Li, Xiaoming, Mingfeng Xia, Hui Ma, et al.. (2013). Liver Fat Content, Evaluated through Semi-Quantitative Ultrasound Measurement, Is Associated with Impaired Glucose Profiles: A Community-Based Study in Chinese. PLoS ONE. 8(7). e65210–e65210. 21 indexed citations

20.

Yan, Hongmei, Mingfeng Xia, Xinxia Chang, et al.. (2011). Circulating Fibroblast Growth Factor 21 Levels Are Closely Associated with Hepatic Fat Content: A Cross-Sectional Study. PLoS ONE. 6(9). e24895–e24895. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact